Spahn, M

[How should hormone therapy for castration-resistant prostate cancer be continued?]. [electronic resource] - Der Urologe. Ausg. A Jan 2012 - 15-9 p. digital

Publication Type: English Abstract; Journal Article

1433-0563

10.1007/s00120-011-2738-9 doi


Androgen Antagonists--therapeutic use
Antineoplastic Agents--therapeutic use
Castration
Combined Modality Therapy
Estrogen Antagonists--therapeutic use
Humans
Male
Prostatic Neoplasms--diagnosis
Treatment Failure